Hepatic RNA interference: delivery by synthetic vectors

[1]  Robert K. Barnes,et al.  Poly(ethylene glycol) , 2014 .

[2]  Alan McLachlan,et al.  Hepatocyte-targeted RNAi Therapeutics for the Treatment of Chronic Hepatitis B Virus Infection , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[3]  K. Ishii,et al.  Hydrophobic blocks of PEG-conjugates play a significant role in the accelerated blood clearance (ABC) phenomenon. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[4]  Darren H. Wakefield,et al.  Co-injection of a targeted, reversibly masked endosomolytic polymer dramatically improves the efficacy of cholesterol-conjugated small interfering RNAs in vivo. , 2012, Nucleic acid therapeutics.

[5]  G. Sinha.  Interest resparks in RNAi , 2012, Nature Biotechnology.

[6]  Daniel G. Anderson,et al.  Molecularly Self-Assembled Nucleic Acid Nanoparticles for Targeted In Vivo siRNA Delivery , 2012, Nature nanotechnology.

[7]  P. Couvreur,et al.  Lipid conjugated oligonucleotides: a useful strategy for delivery. , 2012, Bioconjugate chemistry.

[8]  M. Manoharan,et al.  Comprehensive evaluation of canonical versus Dicer-substrate siRNA in vitro and in vivo. , 2012, RNA.

[9]  J. Kwekkeboom,et al.  Hepatic cell-to-cell transmission of small silencing RNA can extend the therapeutic reach of RNA interference (RNAi) , 2011, Gut.

[10]  T. LaBean,et al.  Nucleic acid-based nanoengineering: novel structures for biomedical applications , 2011, Interface Focus.

[11]  Yang Liu,et al.  In vivo delivery of RNAi with lipid-based nanoparticles. , 2011, Annual review of biomedical engineering.

[12]  Bingqing Wang,et al.  Effects of hydrophobic and hydrophilic modifications on gene delivery of amphiphilic chitosan based nanocarriers. , 2011, Biomaterials.

[13]  David D. Smith,et al.  Dual functional RNA nanoparticles containing phi29 motor pRNA and anti-gp120 aptamer for cell-type specific delivery and HIV-1 inhibition. , 2011, Methods.

[14]  T. Andresen,et al.  Revisit complexation between DNA and polyethylenimine--effect of length of free polycationic chains on gene transfection. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[15]  Charles Schmidt.  RNAi momentum fizzles as pharma shifts priorities , 2011, Nature Biotechnology.

[16]  Joseph M. DeSimone,et al.  Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles , 2011, Proceedings of the National Academy of Sciences.

[17]  George A. Calin,et al.  RNA interference in the clinic: challenges and future directions , 2011, Nature Reviews Cancer.

[18]  M. J. Simard,et al.  Argonaute pull-down and RISC analysis using 2'-O-methylated oligonucleotides affinity matrices. , 2011, Methods in molecular biology.

[19]  U. Schubert,et al.  Poly(ethylene glycol) in drug delivery: pros and cons as well as potential alternatives. , 2010, Angewandte Chemie.

[20]  John Maraganore,et al.  A status report on RNAi therapeutics , 2010, Silence.

[21]  K. G. Rajeev,et al.  Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[22]  Faisal A. Aldaye,et al.  Loading and selective release of cargo in DNA nanotubes with longitudinal variation. , 2010, Nature chemistry.

[23]  M. Baker.  RNA interference: Homing in on delivery , 2010, Nature.

[24]  Yu-cheng Tseng,et al.  Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[25]  K. G. Rajeev,et al.  Rational design of cationic lipids for siRNA delivery , 2010, Nature Biotechnology.

[26]  Kathryn A. Whitehead,et al.  Lipid-like materials for low-dose, in vivo gene silencing , 2010, Proceedings of the National Academy of Sciences.

[27]  N. Stanietsky,et al.  The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity , 2009, Proceedings of the National Academy of Sciences.

[28]  Alex H de Vries,et al.  A coarse-grained model for polyethylene oxide and polyethylene glycol: conformation and hydrodynamics. , 2009, The journal of physical chemistry. B.

[29]  R. Pierce,et al.  Solid polymeric microparticles enhance the delivery of siRNA to macrophages in vivo , 2009, Nucleic acids research.

[30]  Eun-Mi Kim,et al.  Superparamagnetic iron oxide nanoparticles-loaded chitosan-linoleic acid nanoparticles as an effective hepatocyte-targeted gene delivery system. , 2009, International journal of pharmaceutics.

[31]  Daniel G. Anderson,et al.  Knocking down barriers: advances in siRNA delivery , 2009, Nature Reviews Drug Discovery.

[32]  G. Musso,et al.  Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). , 2009, Progress in lipid research.

[33]  Robert Langer,et al.  Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates , 2008, Proceedings of the National Academy of Sciences.

[34]  Leaf Huang,et al.  Pharmacokinetics and biodistribution of nanoparticles. , 2008, Molecular pharmaceutics.

[35]  L. Glimcher,et al.  Regulation of Hepatic Lipogenesis by the Transcription Factor XBP1 , 2008, Science.

[36]  D. Ly,et al.  Peptide Nucleic Acids (PNAs) , 2008 .

[37]  Daniel G. Anderson,et al.  Heme oxygenase-1 is an anti-inflammatory host factor that promotes murine plasmodium liver infection. , 2008, Cell Host and Microbe.

[38]  Robert Langer,et al.  A combinatorial library of lipid-like materials for delivery of RNAi therapeutics , 2008, Nature Biotechnology.

[39]  Junji Kato,et al.  Resolution of liver cirrhosis using vitamin A–coupled liposomes to deliver siRNA against a collagen-specific chaperone , 2008, Nature Biotechnology.

[40]  Russell P. Goodman,et al.  Reconfigurable, braced, three-dimensional DNA nanostructures. , 2008, Nature nanotechnology.

[41]  D. Sparks,et al.  Linoleic acid-enriched phospholipids act through peroxisome proliferator-activated receptors alpha to stimulate hepatic apolipoprotein A-I secretion. , 2008, Biochemistry.

[42]  M. Stoffel,et al.  Mechanisms and optimization of in vivo delivery of lipophilic siRNAs , 2007, Nature Biotechnology.

[43]  M. Bawendi,et al.  Renal clearance of quantum dots , 2007, Nature Biotechnology.

[44]  Tao Wang,et al.  Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity. , 2007, The Journal of clinical investigation.

[45]  Darren H. Wakefield,et al.  Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes , 2007, Proceedings of the National Academy of Sciences.

[46]  J. Mitchell,et al.  Critical role of toll-like receptors and nucleotide oligomerisation domain in the regulation of health and disease. , 2007, The Journal of endocrinology.

[47]  R. Bruno,et al.  Prophylaxis and treatment of hepatitis B in immunocompromised patients. , 2007, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[48]  Tariq M Rana,et al.  Design and creation of new nanomaterials for therapeutic RNAi. , 2007, ACS chemical biology.

[49]  T. P. Prakash,et al.  2'-Modified oligonucleotides for antisense therapeutics. , 2007, Current topics in medicinal chemistry.

[50]  Wim E Hennink,et al.  Pharmacokinetics of poly(hydroxyethyl-l-asparagine)-coated liposomes is superior over that of PEG-coated liposomes at low lipid dose and upon repeated administration. , 2007, Biochimica et biophysica acta.

[51]  John J. Rossi,et al.  Strategies for silencing human disease using RNA interference , 2007, Nature Reviews Genetics.

[52]  J. Chardigny,et al.  Upregulation of liver VLDL receptor and FAT/CD36 expression in LDLR−/− apoB100/100 mice fed trans-10,cis-12 conjugated linoleic acid1 Published, JLR Papers in Press, September 6, 2006. , 2006, Journal of Lipid Research.

[53]  Andrew J Turberfield,et al.  Single-molecule protein encapsulation in a rigid DNA cage. , 2006, Angewandte Chemie.

[54]  Jia-cong Shen,et al.  The development and characterization of a glutathione-sensitive cross-linked polyethylenimine gene vector. , 2006, Biomaterials.

[55]  Leaf Huang,et al.  Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells. , 2006, Molecular pharmaceutics.

[56]  Matthias John,et al.  RNAi-mediated gene silencing in non-human primates , 2006, Nature.

[57]  Yusuke Doi,et al.  Synthesis and characterization of oligonucleotides containing 2′-fluorinated thymidine glycol as inhibitors of the endonuclease III reaction , 2006, Nucleic acids research.

[58]  U. Edvardsson,et al.  PPARα activation increases triglyceride mass and adipose differentiation-related protein in hepatocytes Published, JLR Papers in Press, November 10, 2005. , 2006, Journal of Lipid Research.

[59]  Mark E. Davis,et al.  Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imaging , 2006, Nucleic acids research.

[60]  David P. Bartel,et al.  Passenger-Strand Cleavage Facilitates Assembly of siRNA into Ago2-Containing RNAi Enzyme Complexes , 2005, Cell.

[61]  T. Hibi,et al.  Tumour necrosis factor α signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice , 2005, Gut.

[62]  Mark E. Davis,et al.  A nanoparticle-based model delivery system to guide the rational design of gene delivery to the liver. 2. In vitro and in vivo uptake results. , 2005, Bioconjugate chemistry.

[63]  Keith Bowman,et al.  Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs , 2005, Nature Biotechnology.

[64]  A. Göpferich,et al.  Polyethylenimine-based non-viral gene delivery systems. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[65]  V. Soriano,et al.  Management of patients co-infected with hepatitis B virus and HIV. , 2005, The Lancet. Infectious diseases.

[66]  R. Griffey,et al.  Positional effect of chemical modifications on short interference RNA activity in mammalian cells. , 2005, Journal of medicinal chemistry.

[67]  R. Hammer,et al.  Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[68]  K. Leong,et al.  Galactosylated ternary DNA/polyphosphoramidate nanoparticles mediate high gene transfection efficiency in hepatocytes. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[69]  Sangdun Choi,et al.  Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy , 2005, Nature Biotechnology.

[70]  Matthias John,et al.  Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs , 2004, Nature.

[71]  J. Nah,et al.  Galactosylated chitosan/DNA nanoparticles prepared using water-soluble chitosan as a gene carrier. , 2004, Biomaterials.

[72]  F. Szoka,et al.  Chloride Accumulation and Swelling in Endosomes Enhances DNA Transfer by Polyamine-DNA Polyplexes* , 2003, Journal of Biological Chemistry.

[73]  G. Hardee,et al.  Pharmacokinetics of a tumor necrosis factor-alpha phosphorothioate 2'-O-(2-methoxyethyl) modified antisense oligonucleotide: comparison across species. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[74]  Robert H. Silverman,et al.  Activation of the interferon system by short-interfering RNAs , 2003, Nature Cell Biology.

[75]  B. Li,et al.  Expression profiling reveals off-target gene regulation by RNAi , 2003, Nature Biotechnology.

[76]  Y. Shaul,et al.  Inhibition of hepatitis B virus expression and replication by RNA interference , 2003, Hepatology.

[77]  I. N. Crispe,et al.  Hepatic T cells and liver tolerance , 2003, Nature Reviews Immunology.

[78]  P. Opolon,et al.  Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo. , 2002, Biochemical and biophysical research communications.

[79]  Filip Braet,et al.  Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: a review , 2002, Comparative hepatology.

[80]  T. V. van Berkel,et al.  Determination of the Upper Size Limit for Uptake and Processing of Ligands by the Asialoglycoprotein Receptor on Hepatocytesin Vitro and in Vivo * , 2001, The Journal of Biological Chemistry.

[81]  P. Cullis,et al.  On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids , 2001, Gene Therapy.

[82]  A. Maruyama,et al.  Receptor-mediated cell modulator delivery to hepatocyte using nanoparticles coated with carbohydrate-carrying polymers. , 2001, Biomaterials.

[83]  Guisheng Zhang,et al.  Long-term expression of human alpha1-antitrypsin gene in mouse liver achieved by intravenous administration of plasmid DNA using a hydrodynamics-based procedure , 2000, Gene Therapy.

[84]  A. Diehl,et al.  Altered hepatic lymphocyte subpopulations in obesity‐related murine fatty livers: Potential mechanism for sensitization to liver damage , 2000, Hepatology.

[85]  R. Geary,et al.  Absorption of antisense oligonucleotides in rat intestine: effect of chemistry and length. , 2000, Antisense & nucleic acid drug development.

[86]  S. Friedman.  Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury* , 2000, The Journal of Biological Chemistry.

[87]  Dexi Liu,et al.  Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA , 1999, Gene Therapy.

[88]  G. Koning,et al.  On the mechanism of hepatic transendothelial passage of large liposomes , 1999, FEBS letters.

[89]  Eugene R. Schiff,et al.  Schiff's Diseases of the Liver , 1999 .

[90]  Amarpreet S. Sawhney,et al.  Poly(ethylene glycol) , 1999 .

[91]  N. Abumrad,et al.  Membrane transport of long-chain fatty acids: evidence for a facilitated process. , 1998, Journal of lipid research.

[92]  S. W. Kim,et al.  Lactose-poly(ethylene glycol)-grafted poly-L-lysine as hepatoma cell-tapgeted gene carrier. , 1998, Bioconjugate chemistry.

[93]  A. Jaschke.  Oligonucleotide—Poly(ethylene glycol) Conjugates: Synthesis, Properties, and Applications , 1998 .

[94]  A. Fire,et al.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans , 1998, Nature.

[95]  H. Okamura,et al.  Propionibacterium acnes treatment diminishes CD4+ NK1.1+ T cells but induces type I T cells in the liver by induction of IL-12 and IL-18 production from Kupffer cells. , 1997, Journal of immunology.

[96]  T. V. van Berkel,et al.  Particle size determines the specificity of apolipoprotein E-containing triglyceride-rich emulsions for the LDL receptor versus hepatic remnant receptor in vivo. , 1997, Journal of lipid research.

[97]  O. Schiraldi,et al.  CD45RA and CD45RO isoform expression on intrahepatic T-lymphocytes in chronic hepatitis C. , 1997, Microbios.

[98]  F. Szoka,et al.  Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. , 1996, Biochemistry.

[99]  D. Waters,et al.  Hyperlipidemia and coronary disease. Correction of the increased thrombogenic potential with cholesterol reduction. , 1995, Circulation.

[100]  J. Lohler,et al.  Murine hepatitis caused by lymphocytic choriomeningitis virus. II. Cells involved in pathogenesis. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[101]  G. V. van Eys,et al.  Putative membrane fatty acid translocase and cytoplasmic fatty acid-binding protein are co-expressed in rat heart and skeletal muscles. , 1995, Biochemical and biophysical research communications.

[102]  A A Bogdanov,et al.  Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity. , 1994, Biochimica et biophysica acta.

[103]  E. De Clercq,et al.  Synthesis and antiherpes virus activity of 1,5-anhydrohexitol nucleosides. , 1993, Journal of medicinal chemistry.

[104]  L. Huang,et al.  Role of liposome size and RES blockade in controlling biodistribution and tumor uptake of GM1-containing liposomes. , 1992, Biochimica et biophysica acta.

[105]  Peter E. Nielsen,et al.  Peptide nucleic acids (PNA) : oligonucleotide analogues with an achiral peptide backbone , 1992 .

[106]  G. Béréziat,et al.  Selective channelling of arachidonic and linoleic acids into glycerolipids of rat hepatocytes in primary culture. , 1988, Biochemical Journal.

[107]  R. Townsend,et al.  Binding of synthetic oligosaccharides to the hepatic Gal/GalNAc lectin. Dependence on fine structural features. , 1983, The Journal of biological chemistry.

[108]  Y. Rahman,et al.  Differential uptake of liposomes varying in size and lipid composition by parenchymal and kupffer cells of mouse liver. , 1982, Life sciences.

[109]  J. White,et al.  Effect of cholesterol on production of thromboxane b2 by platelets in vitro. , 1980, The New England journal of medicine.

[110]  R. Ross,et al.  Hyperlipidemia and atherosclerosis. , 1976, Science.

[111]  THE JOURNAL OF PHYSICAL CHEMISTRY B , 2022 .